Liver resection and cyst fenestration in the treatment of severe polycystic liver disease

Florencia Que, David M. Nagorney, John B. Gross, Vicente E. Torres

Research output: Contribution to journalArticlepeer-review

156 Scopus citations


Background/Aims: There is limited information on treatment options for massive, highly symptomatic polycystic liver disease. The aim of the study was to analyze the immediate and long-term outcome of combined liver resection and fenestration. Methods: Information was abstracted from medical records. Follow-up was obtained by mailed questionnaire. Liver volume was quantified by computed tomography. Results: Thirty-one patients underwent liver resection and fenestration between July 1985 and June 1993. Mean liver volume was 9357 mL before and 3567 mL after surgery. There was one death from postoperative intracerebral bleed. Eighteen patients experienced complications, usually transient pleural effusions or transient ascites. Twenty-eight of 29 surviving patients with adequate follow-up have experienced immediate and sustained relief of symptoms and improvement in quality of life. After median follow-up of 2.4 years (range, 0.2 to 7.9 years), most patients have not had clinically significant enlargement of the liver. Sequential computed tomography scans before and after surgery suggest that hepatic enlargement in the age range of the patients in the study mainly resulted from the expansion of existing cysts rather than from the development of new cysts. Conclusions: Selected patients with severe symptomatic polycystic liver disease and favorable anatomy benefit from liver resection and fenestration with acceptable morbidity and mortality. The extent of hepatic resection and fenestration is important for the long-term effectiveness of this procedure.

Original languageEnglish (US)
Pages (from-to)487-494
Number of pages8
Issue number2
StatePublished - Feb 1995

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Liver resection and cyst fenestration in the treatment of severe polycystic liver disease'. Together they form a unique fingerprint.

Cite this